Fedez raises the alarm about the shortage of pancreatic enzymes. The rapper, husband of Chiara Ferragni, underwent pancreatic cancer surgery in March 2022 and takes this drug which replaces the functions of a removed or reduced organ, necessary for patients to assimilate food. “I’m receiving lots of emails about a problem I also encountered – Fedez begins in his Instagram Stories -. Having had pancreatic surgery, like all people like me I need to take pancreatic enzymes to be able to eat and assimilate food, and we are having problems. There seems to be only one company that produces them, and it seems they haven’t been found for a month now.” And again: “A problem that I’m also experiencing – explains the rapper – I had a small supply of pancreatic enzymes aside, I’m running out of them and I can’t find them.” “How can this be solved? Without it we can’t eat, we don’t assimilate anything and when we go to the bathroom it’s not fun“, adds Fedez who then publishes a series of messages in which various users point out that the problem is felt by many. “It would seem that the issue is bigger than it seemed at the beginning and that in northern Italy it is no longer there. Send us your emails so we will contact AIFA,” he concludes, tagging il in his stories Ministry of Health
The note from the Ministry of Health: “We are following the issue” – And the Ministry’s reply was not long in coming: “Regarding the deficiency of pancreatic enzymes, it is specified that the issue specifically concerns the Creon drug. This is a known situation and independent of the regulatory activities of Aifa, which has already provided patients and healthcare workers with adequate operational information for some time”, we read in a note. “To date the only manufacturing company (Viatris Italia Srl) has communicatedor the inability to satisfy demand due to excess demand – continues the Ministry – However, as already communicated by AIFA through the procedures ordinarily used in case of drug shortages, the Agency allows healthcare facilities to import similar drugs authorized abroad, in the event that the facilities themselves should encounter discontinuities in supply, at the level of the distribution networks to which they have access – he underlines – Furthermore, pharmacies that cannot find the product in the usual distribution channels can place a direct order to the owner through the appropriate Customer Service service”. The Ministry of Health concludes by making it known that it “follows the issue, as well as all those relating to cases of drug shortages, with great attention and implements all relevant activities aimed at guaranteeing therapeutic continuity for patients”.
Aifa’s information: “Quoted distribution until 2025” – The first signs of shortages of this drug arrived as early as the autumn of 2023, when the Italian Medicines Agency sent healthcare workers an information note announcing that distribution will probably be limited until 2025. “Because of production problems/high demand for medicines based on pancrelipase Creon* 10,000, Creon* 25,000 and Creonipe* 35,000 – explains AIFA in the note dated 25 October 2023, with the owner/sales licensee Viatris Italia Srl – are currently distributed on a quota basis; this situation will presumably continue until 12/31/2025. The shortage is not due to safety or quality issues and has already been communicated to the Regulatory Authority in accordance with current legislation”. AIFA therefore invites healthcare workers to prescribe these drugs “only for authorized indicationsto inform patients already under treatment also in order to avoid hoarding phenomena and to prescribe Creon 10,000 and 25,000 and Creonipe 35,000 only if strictly necessary, in the minimum effective dose, and if for the indication in question there are no valid therapeutic alternatives or if , for patients undergoing treatment, it is not possible to switch to other medicines. This is to ensure that the available packages, as they are limited, are used for indications for which the medicine cannot be replaced”.
by Editorial Staff Daily fact
News in the mail
You will receive all the updates on the world of SO in your inbox
Sign up for free ⤹